ACET ADICET BIO INC Product Launches 8-K Filing 2025 - Clinical Trial Update Adicet Bio, Inc. updated on its clinical trial enrollment, reporting 3 patients enrolled in both its ADI-001 Lupus Nephritis and ADI-270 ccRCC programs, with preliminary results expected in the first half of 2025.Get access to all SEC 8-K filings of the ADICET BIO INC